During the Trading Day
9.62 +0.05 / +0.52%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
9.62 -0.0012 / -0.01%
Volume: 117.2K
Health Technology

Company Description

PDL BioPharma, Inc. is a biotech company engaged in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies. It has focused on intellectual property asset management, investing in new royalty bearing assets and maximizing the value of its patent portfolio and related assets. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Incline Village, NV.

Contact Information

PDL BioPharma, Inc.
932 Southwood Boulevard
Incline Village Nevada 89451
P:(775) 832-8500
Investor Relations:



Other institutional48.60%
Mutual fund holders42.12%
Individual stakeholders2.50%

Top Executives

John Peter McLaughlinPresident, Chief Executive Officer & Director
Peter S. GarciaChief Financial Officer & Vice President
Christopher Lewis StoneSecretary, Vice President & General Counsel
Eric A. EmeryVice President-Manufacturing
Danny J. HartDeputy General Counsel & Assistant Secretary

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.